Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 341.2 USD 0.63%
Market Cap: 10.6B USD
Have any thoughts about
Medpace Holdings Inc?
Write Note

Medpace Holdings Inc
Investor Relations

Medpace Holdings Inc., a name renowned in the clinical research sector, operates at the heart of the drug development process. Founded in 1992 by Dr. August Troendle, Medpace carved a niche for itself as a full-service clinical contract research organization (CRO). The essence of its operation lies in managing the complex journey of bringing new pharmaceuticals and medical devices from conception through to approval. Medpace partners with various biopharmaceutical companies to design, conduct, and oversee clinical trials, aligning with regulatory requirements to ensure these products are safe and effective. The company stands out by offering a comprehensive suite of services, including strategic consulting, project management, and the integration of cutting-edge technologies—a holistic approach that often distinguishes it from competitors.

The engine driving Medpace’s profitability is its model of operational excellence fueled by its disciplined and integrated approach. The company generates revenue primarily from the contracts it secures with sponsors for conducting each phase of clinical trials. By closely collaborating with its clients, Medpace ensures tailored solutions that operate under specified timelines and budgets, enhancing client retention and attracting new business. What truly underlines Medpace’s financial success is its ability to deliver high-quality results, evidenced by robust data captured during trials and the attainment of key endpoints. This reputation for quality not only nurtures client trust but also consolidates Medpace's standing as a pivotal player in the CRO industry, securing a sustainable revenue stream and ongoing growth in a competitive landscape.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. August James Troendle M.D.
Chairman & CEO
No Bio Available
Mr. Jesse J. Geiger BBA, CPA
President
No Bio Available
Mr. Stephen P. Ewald J.D.
Chief Compliance Officer, General Counsel & Corporate Secretary
No Bio Available
Brandon Ebken
Chief Information Officer
No Bio Available
Ms. Lauren Morris
Associate Director of Investors Relations
No Bio Available
Mr. Todd Meyers
Vice President of Business Development & Marketing
No Bio Available
John T. Wynne MBA
Senior Vice President of Commercial Operations & Clinical Pharmacology Unit
No Bio Available
Mr. Reinilde Heyrman M.D.
Chief Medical Officer of Medical Department
No Bio Available
Gina Leisring M.P.H.
Senior Vice President of Clinical Monitoring
No Bio Available

Contacts

Address
OHIO
Cincinnati
5375 Medpace Way
Contacts
+15135799911.0
investor.medpace.com